Sign in

CIK 0001725160

  • Non-accelerated filer
  • Smaller reporting company

Zentalis Pharmaceuticals, Inc.

Sign in to watch
Ticker
ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
823607803
Phone
+1 858-263-4333
Business address
10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 24 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-05 SUN ANTHONY Y President & CEO Sale −37,144 $43.37 $1.6M 1,703,435
2021-04-05 SUN ANTHONY Y President & CEO Sale −400 $44.21 $18K 1,703,035
2021-04-05 SUN ANTHONY Y President & CEO Sale −224 $45.06 $10K 1,702,811
2021-04-05 Johnson David Michael Director Sale −12,897 $43.50 $561K 88,855
2021-04-01 Bunker Kevin D. Chief Operating Officer Sale −2,436 $43.09 $105K 56,504
2021-04-01 Bunker Kevin D. Chief Operating Officer Sale −1,674 $43.88 $73K 54,830
2021-04-01 Bunker Kevin D. Chief Operating Officer Sale −100 $44.90 $4K 54,730
2021-03-10 Bunker Kevin D. Chief Operating Officer Sale −4,720 $45.24 $214K 58,940
2021-03-03 Bunker Kevin D. Chief Operating Officer Sale −3,700 $45.07 $167K 63,660
2021-03-01 Bunker Kevin D. Chief Operating Officer Sale −4,210 $41.65 $175K 67,360
2021-03-01 SUN ANTHONY Y President & CEO Sale −7,599 $41.13 $313K 1,786,568
2021-03-01 SUN ANTHONY Y President & CEO Sale −19,195 $41.92 $805K 1,767,373
2021-03-01 Gallagher Cam Director Sale −10,000 $41.69 $417K 563,942
2021-03-01 Epperly Melissa B, Chief Financial Officer Sale −3,083 $41.67 $128K 283,430
2021-02-11 Epperly Melissa B, Chief Financial Officer Grant or award +15,000 286,513
2021-02-11 Epperly Melissa B, Chief Financial Officer Grant or award · Stock Option (Right to Buy) +45,000 45,000
2021-02-11 Pinto Alexis Chief Legal Officer Grant or award +6,250 6,250
2021-02-11 Pinto Alexis Chief Legal Officer Grant or award · Stock Option (Right to Buy) +18,750 18,750
2021-02-11 Bunker Kevin D. Chief Operating Officer Grant or award +18,750 1,044,464
2021-02-11 Bunker Kevin D. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +56,250 56,250

Page 25 of 28 · 545 trades